This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1984:15:68-75.

Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function

C Picard-Fraire

PMID: 6385655

Review

Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function

C Picard-Fraire. Agents Actions Suppl. 1984.

. 1984:15:68-75.

Author

C Picard-Fraire

PMID: 6385655

No abstract available

PubMed Disclaimer

Similar articles

The effect of oral ticlopidine on arachidonic acid products in human platelets.
Bruno JJ, Chang LF, McSpadden MM, Yang D. Bruno JJ, et al. Agents Actions Suppl. 1984;15:76-87. Agents Actions Suppl. 1984. PMID: 6435408 No abstract available.
[Evaluation of platelet aggregation in patients treated with ticlopidine].
Sbalzarini G, Carniti E, Fiorini L, Iezzi BG. Sbalzarini G, et al. Clin Ter. 1984 Nov 15;111(3):247-50. Clin Ter. 1984. PMID: 6240365 Italian. No abstract available.
Antiplatelet drugs and thrombosis prevention: ticlopidine in perspective.
de Gaetano G, Bertelé V. de Gaetano G, et al. Arq Bras Cardiol. 1983 Dec;41(6):425-7. Arq Bras Cardiol. 1983. PMID: 6678584 No abstract available.
Ticlopidine hydrochloride: relationship between dose, kinetics, plasma concentration and effect on platelet function.
Picard-Fraire C. Picard-Fraire C. Thromb Res Suppl. 1983;4:119-28. doi: 10.1016/0049-3848(83)90367-5. Thromb Res Suppl. 1983. PMID: 6356462 Review.
Overview: pharmacology of ticlopidine.
Gordon JL. Gordon JL. Agents Actions Suppl. 1984;15:108-15. doi: 10.1007/BF01966992. Agents Actions Suppl. 1984. PMID: 6385643 Review. No abstract available.

See all similar articles

Cited by

The P2Y(12) receptor as a target of antithrombotic drugs.
O'Connor S, Montalescot G, Collet JP. O'Connor S, et al. Purinergic Signal. 2011 Sep;7(3):325-32. doi: 10.1007/s11302-011-9241-z. Epub 2011 Jun 28. Purinergic Signal. 2011. PMID: 21710143 Free PMC article. No abstract available.
Clinical pharmacokinetics of ticlopidine.
Desager JP. Desager JP. Clin Pharmacokinet. 1994 May;26(5):347-55. doi: 10.2165/00003088-199426050-00003. Clin Pharmacokinet. 1994. PMID: 8055680 Review.
Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.
Saltiel E, Ward A. Saltiel E, et al. Drugs. 1987 Aug;34(2):222-62. doi: 10.2165/00003495-198734020-00003. Drugs. 1987. PMID: 3304967 Review.
Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.
Shah J, Teitelbaum P, Molony B, Gabuzda T, Massey I. Shah J, et al. Br J Clin Pharmacol. 1991 Dec;32(6):761-4. Br J Clin Pharmacol. 1991. PMID: 1768571 Free PMC article.
Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel.
Gay SC, Roberts AG, Maekawa K, Talakad JC, Hong WX, Zhang Q, Stout CD, Halpert JR. Gay SC, et al. Biochemistry. 2010 Oct 12;49(40):8709-20. doi: 10.1021/bi100914z. Epub 2010 Sep 15. Biochemistry. 2010. PMID: 20815363 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information